+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novavax Inc - logo

Novavax is a clinical-stage vaccine company that develops recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization, seasonal quadrivalent influenza and pandemic H7N9 vaccines, a vaccine candidate against Ebola Virus and others. Founded in 1987, it is headquartered in Gaithersburg, Maryland.

Vaccine Adjuvants - Global Market Outlook (2017-2026) - Product Thumbnail Image

Vaccine Adjuvants - Global Market Outlook (2017-2026)

  • Report
  • January 2019
  • 178 Pages
From
From
From
Novel Vaccine Delivery Devices Market, 2019-2030 - Product Thumbnail Image

Novel Vaccine Delivery Devices Market, 2019-2030

  • Report
  • November 2019
  • 403 Pages
From
From
Human Vaccines - Global Strategic Business Report - Product Thumbnail Image

Human Vaccines - Global Strategic Business Report

  • Report
  • October 2018
  • 380 Pages
From
From
Global Vaccine Adjuvants Market Analysis 2019 - Product Thumbnail Image

Global Vaccine Adjuvants Market Analysis 2019

  • Report
  • November 2019
  • 134 Pages
From
From
Global Virus Like Particles Market & Clinical Trial Insight 2023 - Product Thumbnail Image

Global Virus Like Particles Market & Clinical Trial Insight 2023

  • Clinical Trials
  • September 2017
  • 180 Pages
From
From
From
Loading Indicator
adroll